Sanofi says it aims increasingly to employ artificial intelligence in its quest to find single molecules which can hit more than one disease target, thereby increasing the efficacy of future novel medicines.
Its latest collaboration – announced May 9 with AI specialist Exscientia of Scotland – won't be the company's last in...